PMID- 21611835 OWN - NLM STAT- MEDLINE DCOM- 20120208 LR - 20211020 IS - 1573-6903 (Electronic) IS - 0364-3190 (Linking) VI - 36 IP - 10 DP - 2011 Oct TI - Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats. PG - 1740-9 LID - 10.1007/s11064-011-0489-z [doi] AB - We investigated the influence of prenatal amphetamine exposure (PAE) on dopamine (DA) receptors, and dopamine transporter (DAT) in various striatal and limbic subregions and locomotor activity induced by novel environmental conditions and amphetamine at two postnatal ages, 35 days old (prepubertal) and 60 days old (postpubertal). Experiments were carried out on pregnant female Sprague-Dawley rats, which were daily injected with either d-amphetamine sulfate (1 mg/kg) or saline solution (0.9%) for 11 days, from gestation day 11-21. In PAE rats compared to control we found the following: at pre-pubertal age, an enhancement of DA D1 in the dorsolateral area of the caudate-putamen (CPu), CPu-ventral and shell of the nucleus accumbens (NAcc) with a decrement of the DA D3 receptors in NAcc, olfactory tubercle (OT), and the islands of Calleja (IoC); whereas at postpubertal age, an increase in the levels of DAT in the NAcc and fundus of the CPu, and OT along with a decrease in the expression of DA D2 receptors only in the NAcc shell were found in PAE rats compared to control. In addition, amphetamine induces a marked decrease in locomotor activity at postpubertal age in rats with PAE. These results suggest a differential effect of amphetamines on the DAT mechanism of the nervous system during embryonic development of animals with implications in behavior and drug addictions at adulthood age. FAU - Flores, Gonzalo AU - Flores G AD - Instituto de Fisiologia, Universidad Autonoma de Puebla, 14 Sur 6301, San Manuel, 72570 Puebla, CP, Mexico. gflores@siu.buap.mx FAU - de Jesus Gomez-Villalobos, Maria AU - de Jesus Gomez-Villalobos M FAU - Rodriguez-Sosa, Leonardo AU - Rodriguez-Sosa L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110525 PL - United States TA - Neurochem Res JT - Neurochemical research JID - 7613461 RN - 0 (Central Nervous System Stimulants) RN - 0 (Dopamine Agents) RN - 0 (Dopamine Plasma Membrane Transport Proteins) RN - 0 (Receptors, Dopamine) RN - CK833KGX7E (Amphetamine) SB - IM MH - Amphetamine/*pharmacology MH - Animals MH - Autoradiography MH - Behavior, Animal/drug effects MH - Central Nervous System Stimulants/*pharmacology MH - Child MH - Child, Preschool MH - Corpus Striatum/drug effects/metabolism MH - Dopamine Agents/*pharmacology MH - Dopamine Plasma Membrane Transport Proteins/*metabolism MH - Female MH - Humans MH - Infant, Newborn MH - Motor Activity/*drug effects MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - Random Allocation MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Dopamine/*metabolism EDAT- 2011/05/26 06:00 MHDA- 2012/02/09 06:00 CRDT- 2011/05/26 06:00 PHST- 2011/04/26 00:00 [accepted] PHST- 2011/05/26 06:00 [entrez] PHST- 2011/05/26 06:00 [pubmed] PHST- 2012/02/09 06:00 [medline] AID - 10.1007/s11064-011-0489-z [doi] PST - ppublish SO - Neurochem Res. 2011 Oct;36(10):1740-9. doi: 10.1007/s11064-011-0489-z. Epub 2011 May 25.